Pierre Lafaye

Development of nanobodies as theranostic agents against CMY-2-like class C β-lactamases

M. Galleni, M. Vandevenne, A. Vanderplasschen, 2022, bioRxiv.

Structural basis of TMPRSS2 zymogen activation and recognition by the HKU1 seasonal coronavirus

S. Duquerroy, A. Haouz, Atousa Arbabian, 2024, Cell.